New Pill Could Reduce Risk of Hospitalization, Death From COVID-19, But Experts Say Vaccines Remain Best Tool

Pharmaceutical company Merck and Ridgeback Biotherapeutics said they’ve developed a drug that reduces the risk of hospitalization or death for patients with mild or moderate cases of COVID.